Retension Pharmaceuticals
Retension Pharmaceuticals is a startup headquartered in Mclean, United States, founded in 2023. It has raised at least $18.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Retension Pharmaceuticals has raised at least $18.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Retension Pharmaceuticals sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Mclean
- Adelphi Data
- Apira Technologies
- canopie
- JelliSee Ophthalmics
- Permiso Security
- Rilian Technologies
- ScreenSteps
- v.law
- Zephyr AI
Related
Questions and answers
What does Retension Pharmaceuticals do?
Retension Pharmaceuticals is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Retension Pharmaceuticals raised?
At least $18.1m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Retension Pharmaceuticals based?
Retension Pharmaceuticals is headquartered in Mclean, United States.
When was Retension Pharmaceuticals founded?
Retension Pharmaceuticals was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.